Here’s what key metrics tell us about Splot (PLXS)’s Q4 earnings

On By Yukito

Plexus (PLXS) reported revenue of $1.05 billion for the quarter ended September 2024, up 2.6% year-over-year. EPS of $1.85 in the same period compared to $1.44 a year ago.

Reported revenues are in line with the Zacks Consensus Estimate of $1.01 billion, representing a surprise of +4.28%. The company had an EPS surprise of +20.92%, with the consensus EPS estimate coming in at $1.53.

While investors closely monitor year-over-year changes in key numbers – revenue and earnings – and how they compare to Wall Street expectations to determine their next course of action, certain key metrics always provide greater insight into a company’s underlying performance.

Because these metrics play a key role in shaping financial performance and earnings, comparing them with year-ago data and analyst estimates helps investors better forecast stock price behavior.

Here’s how Plexus performed in the just-reported quarter in terms of the metrics most frequently monitored and predicted by Wall Street analysts:

  • Revenue – Market Sector – Healthcare/Life Sciences: $415 million compared to $399.09 million estimated by the average of two analysts. Compared to the previous year’s quarter, this number represents a change of 7.6%.

  • Revenue – Market Sector – Aerospace/Defense: $184 million compared to the $177.82 million estimated by two analysts on average. Compared to the previous year’s quarter, this number represents a change of +16.5%.

  • Revenues – Market sector – Industry: $452 million compared to the average estimate of $432.49 million based on two analysts. The figure represents a change of +8.4% year-on-year.

View all key company metrics for Splot here>>>

Shares of Plexus have gained 2.5% over the past month, compared to a change of 2.7% for the Zacks S&P 500 composite. The stock is currently sporting a Zacks Rank #3 (Hold), which indicates it may be trading higher in the near future. results at the broader market level.

Want the latest recommendations from Zacks Investment Research? Today you can download the top 7 stocks for the next 30 days. Click to get this free report

Plexus Corp. (PLXS): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research